Cyclotides as templates in drug design

Drug Discovery Today

Volumn 15, Issue 1-2, 2010, Pages 57-64

  Henriques, Sónia Troeira ^a,b   Craik, David J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULIN; CYCLOPEPTIDE; CYCLOPSYCHOTRIDE A; CYCLOTIDE; CYCLOVIOLACIN O2; KALATA B1; NEUROTENSIN; PROTEIN MCOTI II; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOENGINEERING; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LD 50; NONHUMAN; REVIEW; TOXICITY TESTING;

AMINO ACID SEQUENCE; ANIMALS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOENGINEERING; CYCLOTIDES; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROTENSIN;

EID: 73749087526     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.10.007     Document Type: Review

References (68)

1. Craik D.J., et al. Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J. Mol. Biol. 294 (1999) 1327-1336
2. Jennings C., et al. Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10614-10619
3. Barbeta B.L., et al. Plant cyclotides disrupt epithelial cells in the midgut of lepidopteran larvae. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 1221-1225
4. Gran L. Isolation of oxytocic peptides from Oldenlandia affinis by solvent extraction of tetraphenylborate complexes and chromatography on sephadex LH-20. Lloydia 36 (1973) 207-208
5. Colgrave M.L., and Craik D.J. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry 43 (2004) 5965-5975
6. Sletten K., and Gran L. Some molecular properties of kalata peptide B-1. A uterotonic polypeptide isolated from Oldenlandia affinis DC. Medd. Nor. Farm. Selsk. 7-8 (1973) 69-82
7. Gran L. An oxytocic principle found in Oldenlandia affinis DC. Medd. Nor. Farm. Selsk. 12 (1970) 173-180
8. Gran L., et al. Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine. J. Ethnopharmacol. 70 (2000) 197-203
9. Saether O., et al. Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry 34 (1995) 4147-4158
10. Pallaghy P.K., et al. A common structural motif incorporating a cystine knot and a triple-stranded β-sheet in toxic and inhibitory polypeptides. Protein Sci. 3 (1994) 1833-1839
11. Craik D.J., et al. The cystine knot motif in toxins and implications for drug design. Toxicon 39 (2001) 43-60
12. Schöpke T., et al. Hämolytisch aktive komponenten aus Viola tricolor L. und Viola arvensis Murray. Sci. Pharm. 61 (1993) 145-153
13. Witherup K.M., et al. Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J. Nat. Prod. 57 (1994) 1619-1625
14. Gustafson K.R., et al. Circulins A and B: novel HIV-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia. J. Am. Chem. Soc. 116 (1994) 9337-9338
15. Göransson U., et al. Seven novel macrocyclic polypeptides from Viola arvensis. J. Nat. Prod. 62 (1999) 283-286
16. Claeson P., et al. Fractionation protocol for the isolation of polypeptides from plant biomass. J. Nat. Prod. 61 (1998) 77-81
17. Craik D.J., et al. Discovery, structure and biological activities of the cyclotides. Curr. Protein Pept. Sci. 5 (2004) 297-315
18. Heitz A., et al. Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins. Biochemistry 40 (2001) 7973-7983
19. Hernandez J.F., et al. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Biochemistry 39 (2000) 5722-5730
20. Craik D.J., et al. The cyclotide family of circular miniproteins: nature's combinatorial peptide template. Biopolym. Peptide Sci. 84 (2006) 250-266
21. Clark R.J., et al. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochem. J. 394 (2006) 85-93
22. Goransson U., et al. The conserved glu in the cyclotide cycloviolacin O2 has a key structural role. ChemBioChem 10 (2009) 2354-2360
23. Wang C.K., et al. Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as a drug scaffold. J. Biol. Chem. 284 (2009) 10672-10683
24. Rosengren K.J., et al. Twists, knots, and rings in proteins. Structural definition of the cyclotide framework. J. Biol. Chem. 278 (2003) 8606-8616
25. Herrmann A., et al. Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2. Cell. Mol. Life Sci. 63 (2006) 235-245
26. Simonsen S.M., et al. Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity. J. Biol. Chem. 283 (2008) 9805-9813
27. Saska I., et al. An asparaginyl endopeptidase mediates in vivo protein backbone cyclisation. J. Biol. Chem. 282 (2007) 29721-29728
28. Gillon A.D., et al. Biosynthesis of circular proteins in plants. Plant J. 53 (2008) 505-515
29. Gustafson K.R., et al. Anti-HIV cyclotides. Curr. Protein Pept. Sci. 5 (2004) 331-340
30. Daly N.L., et al. The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1. FEBS Lett. 574 (2004) 69-72
31. Daly N.L., et al. Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif. Biochem. J. 393 (2006) 619-626
32. Chen B., et al. Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide. J. Biol. Chem. 280 (2005) 22395-22405
33. Ireland D.C., et al. Cyclotides as natural anti-HIV agents. Biopolym. Peptide Sci. 90 (2008) 51-60
34. Wang C.K., et al. Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. J. Nat. Prod. 71 (2008) 47-52
35. Rusconi S., et al. An update in the development of HIV entry inhibitors. Curr. Top. Med. Chem. 7 (2007) 1273-1289
36. Veiga S., et al. Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level. Biochem. J. 377 (2004) 107-110
37. Franquelim H.G., et al. Sifuvirtide screens rigid membrane surfaces. Establishment of a correlation between efficacy and membrane domain selectivity among HIV fusion inhibitor peptides. J. Am. Chem. Soc. 130 (2008) 6215-6223
38. Kamimori H., et al. Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance. Anal. Biochem. 337 (2005) 149-153
39. Shenkarev Z.O., et al. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle. FEBS J. 273 (2006) 2658-2672
40. 2+/DPC micelle. J. Inorg. Biochem. 102 (2008) 1246-1256
41. Huang Y.H., et al. The biological activity of the prototypic cyclotide kalata B1 is modulated by the formation of multimeric pores. J. Biol. Chem. 284 (2009) 20699-20707
42. Gruber C.W., et al. Distribution and evolution of circular miniproteins in flowering plants. Plant Cell 20 (2008) 2471-2483
43. Tam J.P., et al. An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8913-8918
44. Gran L., et al. Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties. Chem. Biodivers. 5 (2008) 2014-2022
45. Daly N.L., et al. Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1. Biochemistry 38 (1999) 10606-10614
46. Lindholm P., et al. Cyclotides: a novel type of cytotoxic agents. Mol. Cancer Ther. 1 (2002) 365-369
47. Herrmann A., et al. The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity. Phytochemistry 69 (2008) 939-952
48. Svangard E., et al. Cytotoxic cyclotides from Viola tricolor. J. Nat. Prod. 67 (2004) 144-147
49. Svangard E., et al. Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranes. J. Nat. Prod. 70 (2007) 643-647
50. Hoskin D.W., and Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 1778 (2008) 357-375
51. Klocek G., et al. Thermodynamics of melittin binding to lipid bilayers. Aggregation/pore formation. Biochemistry 48 (2009) 2586-2596
52. Huang H.W. Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides. Biophys. J. 96 (2009) 3263-3272
53. Skjeldal L., et al. Refined structure and metal binding site of the kalata B1 peptide. Arch. Biochem. Biophys. 399 (2002) 142-148
54. Jennings C.V., et al. Isolation, solution structure, and insecticidal activity of kalata B2, a circular protein with a twist: do Mobius strips exist in nature?. Biochemistry 44 (2005) 851-860
55. Plan M.R.R., et al. Backbone cyclised peptides from plants show molluscicidal activity against the rice pest Pomacea canaliculata (golden apple snail). J. Agric. Food Chem. 56 (2008) 5237-5241
56. Göransson U., et al. Reversible antifouling effect of the cyclotide cycloviolacin O2 against barnacles. J. Nat. Prod. 67 (2004) 1287-1290
57. Colgrave M.L., et al. Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry 47 (2008) 5581-5589
58. Colgrave M.L., et al. The anthelmintic activity of the cyclotides: natural variants with enhanced activity. ChemBioChem 9 (2008) 1939-1945
59. Colgrave M.L., et al. Anthelmintic activity of cyclotides: in vitro studies with canine and human hookworms. Acta Trop. 109 (2009) 163-166
60. Gran L. On the effect of a polypeptide isolated from "Kalata-Kalata" (Oldenlandia affinis DC) on the oestrogen dominated uterus. Acta Pharmacol. Toxicol. (Copenh.) 33 (1973) 400-408
61. Chen B., et al. Cycloviolacin H4, a hydrophobic cyclotide from Viola hederaceae. J. Nat. Prod. 69 (2006) 23-28
62. Craik D.J., et al. The cyclotides and related macrocyclic peptides as scaffolds in drug design. Curr. Opin. Drug Discov. Dev. 9 (2006) 251-260
63. Gunasekera S., et al. Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. J. Med. Chem. 51 (2008) 7697-7704
64. Thongyoo P., et al. Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides. Org. Biomol. Chem. 6 (2008) 1462-1470
65. Greenwood K.P., et al. The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis. Int. J. Biochem. Cell Biol. 39 (2007) 2252-2264
66. Cudic M., and Fields G.B. Extracellular proteases as targets for drug development. Curr. Protein Pept. Sci. 10 (2009) 297-307
67. Kanodia S., and Kast W.M. Peptide-based vaccines for cancer: realizing their potential. Expert Rev. Vaccines 7 (2008) 1533-1545
68. Wang C.K., et al. Despite a conserved cystine knot motif, different cyclotides have different membrane binding modes. Biophys. J. 97 (2009) 1471-1481